In recent years, a quiet but significant shift has been unfolding in the world of mental health: adults are increasingly being diagnosed with attention-deficit/hyperactivity disorder (ADHD)—and more of them are being prescribed medication than ever before.
Once widely considered a childhood condition affecting mostly boys, ADHD is now being recognized in a very different demographic. New research highlighted in a March 2026 report shows that prescriptions for ADHD medications among adults have more than doubled since the start of the COVID-19 pandemic.
But perhaps the most surprising finding is this: the “typical” patient is no longer who many people expect.
A New Face of ADHD
According to recent data, the average adult starting ADHD medication today is a 31-year-old woman living in an urban area.
Even more striking, the fastest-growing group receiving prescriptions is young women aged 18 to 24.
This marks a dramatic shift from decades past, when ADHD diagnoses were heavily concentrated among boys and men. Experts say this change doesn’t necessarily mean ADHD is becoming more common—but rather that it is finally being recognized in groups that were historically overlooked.
For years, ADHD symptoms in women often went undiagnosed. Instead of hyperactivity, which is more visible and common in boys, women are more likely to experience inattentiveness, disorganization, and internal restlessness—symptoms that are easier to miss or misinterpret.
Now, as awareness grows, many women are being diagnosed for the first time in adulthood.
The Pandemic Effect
The COVID-19 pandemic appears to have played a major role in accelerating this trend.
Research shows that new stimulant prescriptions for adults—commonly used to treat ADHD—more than doubled after 2020, with the steepest increases among younger adults.
Several factors tied to the pandemic may explain this surge:
- Increased mental health strain: Disruptions to routines, remote work, and social isolation made it harder for many people to focus and function.
- More time for self-reflection: People began noticing symptoms they had previously ignored.
- Expanded telehealth services: Online consultations made it easier to access diagnosis and treatment.
In fact, telehealth has become a major gateway for ADHD care. One U.S. estimate found that about 30% of adults with ADHD used telehealth services for prescriptions or therapy during the pandemic.
This shift lowered barriers to care—but also introduced new concerns.
Awareness vs. Overdiagnosis
On one hand, the rise in prescriptions may signal progress. ADHD affects millions of adults worldwide, yet many cases have historically gone untreated. Greater awareness and access to care could help people manage symptoms and improve their quality of life.
On the other hand, experts are urging caution.
“The speed and scale of this growth raises important questions about how diagnoses are being made,” researchers noted in a 2026 analysis.
Some worry that:
- Diagnoses may be happening too quickly, especially through online platforms
- Social media may encourage self-diagnosis or misinterpretation of symptoms
- Medications could be prescribed without thorough evaluation
The rise of ADHD-related content on platforms like TikTok and Instagram has played a role in increasing awareness—but it has also blurred the line between education and misinformation.
Social Media’s Influence
In recent years, ADHD has become a trending topic online. Millions of users share personal experiences, symptom checklists, and “relatable” content about focus, procrastination, and productivity struggles.
While this has helped reduce stigma and encouraged people to seek help, it has also led some individuals to assume they have ADHD based on incomplete or oversimplified information.
Researchers warn that this environment can contribute to overdiagnosis or inappropriate treatment, particularly when combined with fast-track telehealth services.
A Global Trend
The surge in ADHD medication is not limited to one country—it’s happening worldwide.
A 2025 study in Canada found that prescriptions for stimulant medications increased by over 150% between 2015 and 2023, with especially sharp rises among women and young adults.
Similarly, European data shows that ADHD medication use has tripled over the past decade, with the most dramatic growth among adult women.
These patterns suggest a broader global shift in how ADHD is understood and treated.
Is ADHD Actually Increasing?
Interestingly, while prescriptions are rising rapidly, the actual prevalence of ADHD may not be increasing at the same rate.
Some research suggests that ADHD itself has remained relatively stable, even as diagnoses and treatment have surged.
This gap raises an important question:
Are more people developing ADHD—or are more people simply being diagnosed?
Most experts believe it’s a combination of:
- Better recognition of symptoms
- Reduced stigma around mental health
- Expanded access to care
However, they also emphasize the need for careful, evidence-based diagnosis.
Benefits—and Risks—of Medication
For those who truly have ADHD, medication can be life-changing. Stimulant medications are considered a first-line treatment and can significantly improve focus, productivity, and daily functioning.
But they are not without risks.
Potential concerns include:
- Side effects such as insomnia, anxiety, or increased heart rate
- Risk of misuse or dependency
- Treating the wrong condition if misdiagnosed
Experts stress that medication should be part of a comprehensive treatment plan, often including therapy, lifestyle changes, and behavioral strategies.
The Bottom Line
The rapid rise in ADHD medication use among adults reflects a major shift in mental health awareness—and a long-overdue recognition that ADHD does not disappear after childhood.
At the same time, the trend raises important questions about how diagnoses are made and whether the healthcare system is keeping pace with demand.
For many, this surge represents progress: more people getting the help they need. For others, it signals the need for caution, ensuring that increased access does not come at the cost of accuracy and safety.
As research continues, one thing is clear: ADHD in adults is no longer under the radar—and the conversation around it is only just beginning.